Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting
- Issued Date
- 2020
- Type
- Article
- Publisher
- Chinese Clinical Oncology
- Language
- 영어
- ISSN
- 2304-3865
- Citation Volume
- 9
- Citation Number
- 5
- Citation Start Page
- 0
- Citation End Page
- 0
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.